Success Metrics

Clinical Success Rate

80.0%

Based on 4 completed trials

Completion Rate

80%(4/5)

Active Trials

1(17%)

Results Posted

25%(1 trials)

Terminated

1(17%)

Phase Distribution

Ph phase_1

33%

Ph phase_3

17%

Ph phase_2

50%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 1Safety & dosage

2(33.3%)

Phase 2Efficacy & side effects

3(50.0%)

Phase 3Large-scale testing

1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(4)

Terminated(1)

Detailed Status

Completed4

Recruiting1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

80.0%

Most Advanced

Phase 3

Trials by Phase

Phase 12 (33.3%)

Phase 23 (50.0%)

Phase 31 (16.7%)

Trials by Status

recruiting117%

completed467%

terminated117%

Recent Activity

1 active trials

Showing 5 of 6

recruitingphase_2

A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia

NCT01831791

View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials

NCT05513365Phase 2

Phase II Dutasteride in Combination With CAB vs CAB in SDC

Recruiting

NCT04677855Phase 1

Study of PCUR-101 in Combination With ADT in Patients With mCRPC

Terminated

NCT04756206Phase 2

Role of Dutasteride in Treatment of Chronic Prostatitis

Completed

NCT04729491Phase 2

EAT-DUTA AndroCoV Trial

Completed

NCT01831791Phase 3

A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia

Completed

NCT03240939Phase 1

Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil

Completed

All 6 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 6